Charles river laboratories acquires samdi tech

Wilmington, mass.--( business wire )--charles river laboratories international, inc. (nyse: crl) announced today that it has acquired samdi tech, inc, a leading provider of high-quality, label-free high-throughput screening (hts) solutions for drug discovery research. the acquisition marks the culmination of a partnership between the companies that began in 2018.
CRL Ratings Summary
CRL Quant Ranking